Preliminary studies on the anti-malarial activity of SDDS (2-sulfamoyl-4, 4'-diaminodiphenylsulfone) against Plasmodium berghei and Plasmodium gallinaceum.
D000818:Animals; D000962:Antimalarials / Q000008:administration & dosage* / Q000494:pharmacology / Q000633:toxicity; D002645:Chickens; D007279:Injections, Subcutaneous; D008288:Malaria / Q000097:blood / Q000188:drug therapy*; D008289:Malaria, Avian / Q000188:drug therapy; D051379:Mice; D010961:Plasmodium / Q000187:drug effects*; D011739:Pyrimethamine / Q000008:administration & dosage; D011803:Quinine / Q000008:administration & dosage; D011804:Quinolines / Q000008:administration & dosage; D051381:Rats; D013450:Sulfones / Q000008:administration & dosage* / Q000378:metabolism / Q000494:pharmacology / Q000633:toxicity; D013552:Swine
D000962:Antimalarials; D011804:Quinolines; D013450:Sulfones; D011803:Quinine; D011739:Pyrimethamine